Friday, April 19, 2024
4/19/2024
Project Summary/ Abstract The gradual loss of insulin-producing beta cells of the endocrine pancreas is common to all forms of diabetes. Elucidating transcriptional complexes that increase our understanding of underlying mechanisms governing pancreatic beta-cell development and function is critical for the development of novel therapeutics that will improve beta-cell function. Loss- and gain-of-function mouse studies have demonstrated critical roles of transcription factors in regulating the establishment and function of beta cells. Preliminary data from our lab and others suggest Lhx1, a LIM-homeodomain transcription factor, is expressed and functions in the developing and adult pancreas. Over the next three years, I propose to investigate in detail the role of Lhx1 in regulating beta-cell development and function using beta cell lines as well as a newly developed conditional knockout model. I hypothesize that Lhx1 is a regulator of endocrine cell development and function. In Aim 1, I will characterize Lhx1 expression at specific developmental and postnatal stages. In Aim 2, I will determine Lhx1 gene regulatory mechanisms in beta cells. In Aim 3, I will characterize the effects of Lhx1 ablation in the developing and adult pancreas using pancreas-specific cre/lox knockout approaches."
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
